Who are dexketoprofen trometamol + tramadol hydrochloride's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Motrin and narcotic, Naproxen Sodium + Codeine Phosphate.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/dexketoprofen-trometamol-tramadol-hydrochloride.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-17 · How we verify

dexketoprofen trometamol + tramadol hydrochloride — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

dexketoprofen trometamol + tramadol hydrochloride (dexketoprofen trometamol + tramadol hydrochloride) competitive landscape: 2 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: NSAID + opioid analgesic combination. Area: Pain Management.

marketed NSAID + opioid analgesic combination COX-1/COX-2 (dexketoprofen); mu-opioid receptor, norepinephrine transporter, serotonin transporter (tramadol) Pain Management Small molecule Live · refreshed every 30 min

Target snapshot

dexketoprofen trometamol + tramadol hydrochloride (dexketoprofen trometamol + tramadol hydrochloride) — Kavaklıdere Umut Hospital. This combination product uses dexketoprofen (a nonsteroidal anti-inflammatory drug) to reduce inflammation and pain, and tramadol (an opioid analgesic) to provide additional pain relief through multiple mechanisms.

Comparator set (2 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
dexketoprofen trometamol + tramadol hydrochloride TARGET	dexketoprofen trometamol + tramadol hydrochloride	Kavaklıdere Umut Hospital	marketed	NSAID + opioid analgesic combination	COX-1/COX-2 (dexketoprofen); mu-opioid receptor, norepinephrine transporter, serotonin transporter (tramadol)
Motrin and narcotic	Motrin and narcotic	Cape Fear Valley Health System	marketed	NSAID + opioid analgesic combination	COX-1/COX-2 (ibuprofen); mu, delta, and kappa opioid receptors (narcotic component)
Naproxen Sodium + Codeine Phosphate	Naproxen Sodium + Codeine Phosphate	ibrahim doğru	marketed	NSAID + opioid analgesic combination	COX-1, COX-2, mu-opioid receptor

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (NSAID + opioid analgesic combination class)

Cape Fear Valley Health System · 1 drug in this class
Kavaklıdere Umut Hospital · 1 drug in this class
ibrahim doğru · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). dexketoprofen trometamol + tramadol hydrochloride — Competitive Intelligence Brief. https://druglandscape.com/ci/dexketoprofen-trometamol-tramadol-hydrochloride. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab